Back to Journals » International Journal of Nanomedicine » Volume 11

Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration

Authors Huang P, Hu SC, Lee C, Yeh A, Tseng C, Yen F

Received 12 November 2015

Accepted for publication 5 February 2016

Published 18 April 2016 Volume 2016:11 Pages 1615—1627

DOI https://doi.org/10.2147/IJN.S100418

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Chenbo Dong

Peer reviewer comments 3

Editor who approved publication: Dr Lei Yang


Pao-Hsien Huang,1,* Stephen Chu-Sung Hu,2,3,* Chiang-Wen Lee,4,5 An-Chi Yeh,6 Chih-Hua Tseng,7 Feng-Lin Yen1,8,9

1Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, 2Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung, 3Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, 4Research Center for Industry of Human Ecology, Chang Gung University of Science and Technology, Kweishan, Taoyuan, 5Department of Nursing, Division of Basic Medical Sciences, Chang Gung University of Science and Technology, Chia-Yi, 6Department of Cosmetics and Fashion Styling, Cheng Shiu University, Kaohsiung, 7School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, 8Lipid Science and Aging Research Center, Kaohsiung Medical University, Kaohsiung, 9Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan

*These authors contributed equally to this work

Abstract:
7,3',4'-Trihydroxyisoflavone (734THIF) is a secondary metabolite of daidzein and has been recently found to possess antioxidant, melanin inhibition, and skin cancer chemopreventive activities. However, the poor water solubility of 734THIF impedes its absorption and skin penetration and, therefore, limits its pharmacological effects when applied topically to the skin. We seek to use the nanoprecipitation method to prepare optimal eudragit E100 (EE)–polyvinyl alcohol (PVA)-loaded 734THIF nanoparticles (734N) to improve its physicochemical properties and thereby increase its water solubility, skin penetration, and biological activities. EE–PVA-loaded 734THIF nanoparticles (734N) were prepared, and their morphology and particle size were evaluated using a particle size analyzer and by electron microscopy. The drug loading and encapsulation efficiencies and in vitro solubility were determined using high-performance liquid chromatography. Hydrogen-bond formation was evaluated by 1H-nuclear magnetic resonance and Fourier transform infrared spectroscopy, and crystalline-to-amorphous transformation was determined by differential scanning calorimetry and X-ray diffractometry. In vitro skin penetration was analyzed using fresh pig skin mounted on Franz diffusion cells, and cytotoxicity against human keratinocyte HaCaT cells was evaluated using the MTT assay. Antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl-free radical scavenging ability. EE–PVA-loaded 734THIF nanoparticles showed good drug loading and encapsulation efficiencies and were characterized by improved physicochemical properties, including reduction in particle size, amorphous transformation, and intermolecular hydrogen-bond formation. This is associated with increased water solubility and enhanced in vitro skin penetration, with no cytotoxicity toward HaCaT cells. In addition, 734THIF nanoparticles retained their antioxidant activity. In conclusion, 734THIF nanoparticles are characterized by improved physicochemical properties, increased water solubility, and enhanced skin penetration, and these may have potential use in the future as a topical delivery formulation for the treatment of skin diseases.

Keywords:
7,3',4'-trihydroxyisoflavone, nanoparticles, water solubility, skin penetration, topical delivery

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]